研究PSENEN在通过树皮细胞相互作用调节NSCLC中西斯普拉丁耐药性的机制
Zhenyu Cao1, Jiaqi Zhu1, Zhe Qin1
1Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
International immunopharmacology
|December 17, 2025
概括
通过影响瘤微环境,PSENEN基因在非小细胞肺癌 (NSCLC) 中促进了对西斯普拉丁的耐药性. 抑制PSENEN可以克服药物耐药性,并提高NSCLC免疫疗法的有效性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 对西斯普拉丁的耐药性是治疗非小细胞肺癌 (NSCLC) 的重大临床挑战.
- 该PSENEN基因与各种癌症有关,其在NSCLC化学抵抗中的作用需要阐明.
研究的目的:
- 调查PSENEN基因在NSCLC中调解西斯普拉丁耐药性的作用.
- 探索PSENEN影响化学抵抗的机制,包括它与瘤微环境的相互作用.
- 评估针对PSENEN在NSCLC中的治疗潜力.
主要方法:
- RNA测序和单细胞RNA测序用于分析PSENEN表达.
- 功能性试验评估PSENEN抑制对细胞增殖,转移和亡的影响.
- 差异表达蛋白质分析 (DIA) 和功能测试,以确定PSENEN效应的调解者.
- 使用药理性PSENEN抑制的体内研究.
- 使用免疫光和免疫组织化学分析免疫微环境.
主要成果:
- 在耐思的NSCLC细胞 (A549/DDP) 中,PSENEN显著上调.
- 在A549/DDP细胞中,抑制PSENEN逆转了西斯普拉丁耐药性,减少了增殖和转移,并增加了细胞亡.
- 通过树皮微环境相互作用,PSENEN影响化学阻力,PPIB被确定为关键调解者.
- 药理上的PSENEN抑制在体内抑制了瘤生长.
- PSENEN表达与免疫细胞透和CD56和PD-1等标记物相关.
结论:
- 在NSCLC中,PSENEN在赋予西斯普拉丁耐药性方面发挥着至关重要的作用,部分是通过 stromal 相互作用.
- 向PSENEN提供了一种潜在的策略,以克服化学抵抗并提高NSCLC的治疗疗效.
- 普森因与免疫标记物的相关性表明,它有可能成为免疫治疗反应的预测生物标记物.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K


